Keeping Tabs on 340B Data to Maximize Savings

Healthcare organizations must develop robust processes and automated monitoring to prepare for the coming changes in the 340B Drug Pricing Program. An impact analysis, solid data analytics, and a clear understanding of provider eligibility will help organizations adapt to the new mega-guidance. This article answers some questions about the intricacies of program compliance.